Literature DB >> 26968050

Value of radiofrequency ablation in the management of retropharyngeal lymphatic malformation.

Quentin Lisan1, Aude Villepelet2, Marine Parodi2, Eréa-Noël Garabedian2, Marie Julie Blouin2, Vincent Couloigner2, Nicolas Leboulanger2.   

Abstract

Lymphatic malformations are benign malformations frequently occurring in the head and neck. Retropharyngeal location is rare, can be life threating and its management is particularly challenging. Over a three-year period, three patients presented with symptomatic (dyspnea and/or dysphagia) retropharyngeal lymphatic malformation. All were treated using a radiofrequency ablation of lymphatic malformation through a trans-oral approach. No major complications occurred following the surgery. During the follow-up, no recurrence was noted and all patients were asymptomatic. Radiofrequency ablation in the management of retropharyngeal lymphatic malformations is a simple technique with very good results and allows a fast recovery with minimum morbidity and a short hospital stay.
Copyright © 2016 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Cystic hygroma; Lymphatic malformation; Radiofrequency ablation; Retropharyngeal; Surgery

Mesh:

Year:  2016        PMID: 26968050     DOI: 10.1016/j.ijporl.2016.01.023

Source DB:  PubMed          Journal:  Int J Pediatr Otorhinolaryngol        ISSN: 0165-5876            Impact factor:   1.675


  3 in total

1.  National Characteristics of Lymphatic Malformations in Children: Inpatient Estimates and Trends in the United States, 2000 to 2009.

Authors:  Jeffrey Cheng; Beiyu Liu; Alfredo E Farjat; Jonathan Routh
Journal:  J Pediatr Hematol Oncol       Date:  2018-04       Impact factor: 1.289

Review 2.  The Role of Interventional Radiologists in the Treatment of Congenital Lymphatic Malformations.

Authors:  Julie Cronan; Anne E Gill; Jay H Shah; C Matthew Hawkins
Journal:  Semin Intervent Radiol       Date:  2020-07-31       Impact factor: 1.513

Review 3.  Recent Progress in Lymphangioma.

Authors:  Xiaowei Liu; Cheng Cheng; Kai Chen; Yeming Wu; Zhixiang Wu
Journal:  Front Pediatr       Date:  2021-12-15       Impact factor: 3.418

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.